The beginning and the evolution of the endovascular treatment of intracranial aneurysms: from the first catheterization of brain arteries to the new stents

Guglielmi, Guido

doi:10.1136/jnis.2009.000422

Cited by 17 publications

(12 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…1 So-called complex aneurysms, being either fusiform or wide-necked ones or (partially thrombosed) giant aneurysms, however, had recurrence rates of 20-30% when treated with GDC coils. 2 For certain subgroups of aneurysms, like sidewall aneurysms in the internal carotid artery's (ICA) ophthalmic segment, alternative strategies were tried, e.g.…”

Section: Introductionmentioning

confidence: 97%

Long-term occlusion results with SILK flow diversion in 28 aneurysms: Do recanalizations occur during follow-up?

et al. 2015

View full text Add to dashboard Cite

Background and purpose The purpose of this article is to report on the long-term success rates of Silk flow-diverter (FD) treatment in a multicenter prospective study for the treatment of complex aneurysms. Methods Between May 2008 and January 2011, all consecutive patients featuring complex intracranial aneurysms eligible for FD treatment with the Silk in three neurovascular centers were included. Clinical and imaging data were assessed during hospitalization and follow-up. Results Five patients were initially asymptomatic, 20 patients showed various neurological symptoms. Twenty-eight FDs were implanted in 25 patients treating 28 aneurysms. The immediate procedure-related morbidity was 8% (two of 25), mortality 0%. One procedure-related death was observed during follow-up (in-stent thrombosis). Compared to the immediate result nearly two of three aneurysms improved during follow-up; all angiographically confirmed inflow changes took place within six months after treatment. Final anatomic outcome in 24 aneurysms of 22 patients comprised 14 (59%) with complete occlusion, seven (29%) with a neck remnant, two (8%) with residual filling <50%, none with residual filling >50% and one (4%) unchanged in comparison to its pretreatment status. Postinterventional recanalizations were seen in three of 13 (23%) aneurysms treated with FD alone; none were observed in 15 aneurysms treated with adjunctive coiling. Conclusion Anatomic presentation and location are key for successful FD treatment. The rate of successful occlusion increases during follow-up. Postinterventional monitoring for at least six months is paramount, as anatomic outcome is not reliably predictable and recanalizations may occur in initially completely occluded aneurysms.

show abstract

Section: Introductionmentioning

confidence: 97%

Long-term occlusion results with SILK flow diversion in 28 aneurysms: Do recanalizations occur during follow-up?

et al. 2015

View full text Add to dashboard Cite

show abstract

“…Endovascular aneurysm treatment was revolutionized by the introduction of endovascular detachable balloon occlusion in 1974 and Guglielmi detachable coil (Boston Scientific, Target, Fremont, CA, USA) embolization in 1991. 3 In the mid-1990s, balloonassisted techniques enhanced the capacity to treat intracranial aneurysms endovascularly. Another similar solution using a stent-assisted technique was popularized in the early 2000s.…”

Section: Introductionmentioning

confidence: 99%

Flow diverters for treatment of intracranial aneurysms: Current status and ongoing clinical trials

Wong

Kwan

et al. 2011

Journal of Clinical Neuroscience

139

View full text Add to dashboard Cite

“…Given the angioarchitecture of wide-necked aneurysms, there is a high risk of progressive coil compaction and coil deposition into the parent vessel leading to complications such as thromboembolism and aneurysm recurrence. 7 Thus, in order to achieve adequate occlusion of widenecked aneurysms, it is often not feasible to perform coil embolization without an assist device.…”

Section: Adjunctive Balloon Devicesmentioning

confidence: 99%

“…In 1995, the first Guglielmi detachable coil was approved by the Food and Drug Administration (FDA), and since then over 300 000 patients have been treated with detachable coils. 2,[7][8][9]10 In the last 15 years, endovascular techniques for the treatment of intracranial aneurysms have evolved at a rapid pace. 11,12 The goal of this review is to describe novel technologies in the treatment of intracranial aneurysms.…”

Section: Introductionmentioning

confidence: 99%

Novel technologies in the treatment of intracranial aneurysms

Zuckerman¹,

Eli²,

Morone³

et al. 2014

Neurological Research

View full text Add to dashboard Cite

The treatment of intracranial aneurysms has undergone precipitous expansion since the first detachable coils were used less than two decades ago. With rapidly expanding technology comes the need to keep all involved parties informed. The objective of our review is to provide a comprehensive, succinct overview of novel paradigms and devices used to treat intracranial aneurysms. We have divided these new technologies into: (1) coils, (2) flow diverters, (3) adjunctive balloon devices, and (4) stents.

show abstract

The beginning and the evolution of the endovascular treatment of intracranial aneurysms: from the first catheterization of brain arteries to the new stents

Cited by 17 publications

References 20 publications

Long-term occlusion results with SILK flow diversion in 28 aneurysms: Do recanalizations occur during follow-up?

Long-term occlusion results with SILK flow diversion in 28 aneurysms: Do recanalizations occur during follow-up?

Flow diverters for treatment of intracranial aneurysms: Current status and ongoing clinical trials

Novel technologies in the treatment of intracranial aneurysms

Contact Info

Product

Resources

About